1-6 of 6
Authors: Gustavo Verdier
Save search
Sort by
Journal Article

P-537. PAIRED - PAtIent Reported Experiences and perceiveD benefit of treatment with dolutegravir/lamivudine (DTG/3TC): a diverse sample of people with HIV-1 reporting high treatment satisfaction, good adherence, and high quality of life

PDF
Jihad Slim and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.736, https://doi.org/10.1093/ofid/ofae631.736
Published: 29 January 2025
Journal Article

P-574. Extrapolating Expected Efficacy, Safety, and Pharmacokinetics (PK) of Dolutegravir/Lamivudine (DTG/3TC) in Pregnant People Living with HIV-1 from Pregnancy Data with Combination DTG and/or 3TC Antiretroviral Therapies

PDF
William R Short and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.772, https://doi.org/10.1093/ofid/ofae631.772
Published: 29 January 2025
Journal Article

1564. Virological Suppression in People with HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)

PDF
Andrew P Brogan and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1399, https://doi.org/10.1093/ofid/ofad500.1399
Published: 27 November 2023
Journal Article

Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis

PDF
Madhusudan Kabra and others
Open Forum Infectious Diseases, Volume 10, Issue 11, November 2023, ofad526, https://doi.org/10.1093/ofid/ofad526
Published: 27 October 2023
Journal Article

1252. A Real-World Observational Study on HIV-Infected Patients who Switched from Nevirapine + 2 Nucleoside Reverse Transcriptase Inhibitors to Dolutegravir/Lamivudine in British Columbia, Canada

PDF
Joss de Wet and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1083, https://doi.org/10.1093/ofid/ofac492.1083
Published: 15 December 2022
Journal Article

1285. Systematic Literature Review of Real-world Experience with the 2-Drug Regimen Dolutegravir and Lamivudine in People with HIV Who Would Not Have Met Inclusion Criteria for the Phase 3 Clinical Program

PDF
Jihad Slim and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1116, https://doi.org/10.1093/ofid/ofac492.1116
Published: 15 December 2022